RE:RE:RE:RE:RE:RE:re: liminal is not prometic.
I think you dont know how investing and financing works in biotech world. You wouldnt have given me 250 million Cash in hand number then. Startups only use less than 10-15 Million a year and 250 Million is lifetime expenses which they usually collect from market by offerings based on results. Noone is giving 250 million to start up. Lol.. Moreover, Liminal has 100 Million cash and drug is expected to go out next year, With burn rate of 20 Million, they can easily get it. Now, just to remind you that this money is without partnership/ partners contribution. If drug is approved, there is no point that we cannoy get a partner. It is easy like a piece of cake to find a partner after approval for commeecialisation... 250 Million. LOLLLLLLLLLLLLLLL.